The Italian TV programme TGR Officina Italia has dedicated a television report about Takis and our research activities to develop a vaccine against Covd-19. We announced our commitment as soon as the genetic sequences of the new Coronavirus became accessible and we have currently 10 researchers of ours working on various aspects of vaccine development.

Luigi Aurisicchio, CEO of Takis and Evvivax, and Emanuele Marra, Director of Infective Diseases Area at Takis, described our genetic vaccination approach and estimated at least one year time for the vaccine to be used in humans.

They also described Takis other research activities in the field of precision oncology and monoclonal antibody production and mentioned our team of young and talented researchers. Proud for that!

Enjoy watching the interview: TGR Officina Itakia – Alla ricerca del vaccino